http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112790909-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-626
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8211609f7f9173ed18e640c97e5d0432
publicationDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112790909-A
titleOfInvention Novel can carry medicine 3D and print amniotic membrane mirror
abstract The present invention relates to an ophthalmic treatment device. The purpose provides a neotype medicine carrying 3D prints amniotic membrane mirror, and this amniotic membrane mirror should have the characteristics that the medicine-carrying capacity is big, need not to have invasive operation, treatment is good. The technical scheme is as follows: the utility model provides a novel can carry medicine 3D and print amnioscope which characterized in that: the amniocentoscope comprises an amniocentesis piece, an upper ring and a lower ring which are overlapped up and down and then clamped and riveted with the amniocentesis piece; tacrolimus liposome thin layers are respectively prepared on the surfaces of the upper ring and the lower ring; the axial projections of the upper ring and the lower ring are in the same elliptical ring shape, the inner ellipse in the middle of the elliptical ring shape is a through hole, and the rest parts are cambered surfaces which are suitable for the eye surface; the amniotic membrane is fixed on the amniotic lens in an unfolded mode and covers the whole through hole.
priorityDate 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID379069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2280
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546

Total number of triples: 32.